Project Grant R01MH135954
Award Date
1/13/25
Completion Date
10/31/29
Dollars Obligated
$742K
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
The National Institute of Mental Health (NIMH) awarded a $4,925,302 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The Washington University to conduct systematic and scalable phenotyping of over 100 mouse mutants for neuropsychiatric disease genetics. The project, which runs from December 1, 2024 to November 30, 2029, will use behavioral analysis, anatomical mapping, and molecular assessments to investigate the impact of prioritized mutations associated with...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $729,821 to the University of Alabama at Birmingham (UAB) to conduct research on the role of long non-coding RNAs (lncRNAs) in the epigenetic regulation and transcriptional repatterning associated with major depressive disorder (MDD). The research aims to mechanistically examine how nuclear lncRNAs regulate 3D chromatin organization and its...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $3,498,931 to Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, to conduct a comprehensive investigation of the impact of loss of 100 neurodevelopmental and psychiatric disorder (NPD) genes in mice. The research aims to elucidate the core biological pathways underlying NPDs by examining gene expression,...
This three-year, $3.456 million project grant from the National Institute of Mental Health (NIMH) Mental Health Research Grants program (CFDA 93.242) will fund research into the role of microglia in neurodevelopmental disorders. The grantee, Cold Spring Harbor Laboratory, will merge two-photon imaging of microglia and synapses in the brains of live mice with single-cell genomics and CRISPR screens. This will help define microglia's role in experience-dependent synaptic refinement, a process...
This $124,488 federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research to map cell type-specific isoform diversity in the human brain and dissect the mechanisms of alternative splicing in autism spectrum disorder (ASD). The project, led by Michael Margolis at the University of California, Los Angeles (UCLA), will leverage long-read sequencing technologies to fully characterize the brain's...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $1,988,947 to the Regents of the University of Michigan to develop a scalable high-plex pipeline for whole-brain proteomics profiling. The goal is to create a 100-plex antibody panel and novel ultra-speed light-sheet microscope and data management system to generate comprehensive proteomic atlases of the whole mouse brain across 6 postnatal...
This federal Project Grant award, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), will fund a $196,597 research project to investigate the information processing changes underlying a high-risk autism spectrum disorder (ASD) gene in rats. The project aims to determine the changes to the hippocampus and its communication with other brain regions in the context of this ASD gene, using advanced techniques such as automated...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants (CFDA 93.242) program, provides $1,369,101 to the University of California, Los Angeles (UCLA) to conduct research on elucidating the regulation of cell fate specification in human cortical development. The goal is to better understand the etiology of neurodevelopmental disorders. The project will evaluate the signals that drive cortical arealization and laminar...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $2,181,744.00 to The Trustees of the University of Pennsylvania to conduct research on the molecular and circuit mechanisms by which neurexin1 (NRXN1) gene mutations contribute to goal-directed dysfunction across neuropsychiatric disorders. The 5-year project, starting on September 25, 2024 and ending on May 31, 2029, will employ...
The National Institute of Mental Health (NIMH) awarded a $439,804 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Creighton University. The grant supports a 5-year research project (11/15/2024 - 10/31/2029) to investigate the role of the lysine methyltransferase 5B (KMT5B) gene in regulating the expression of insulin-like growth factors (IGF1 and IGF2) and their impact on brain development and autism spectrum disorder. The research aims to specify KMT5B's role in...